Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008.

Esposito DH, Tate JE, Kang G, Parashar UD.

Clin Infect Dis. 2011 Jan 15;52(2):171-7. doi: 10.1093/cid/ciq094.

PMID:
21288839
2.

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.

Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S16-27. doi: 10.1086/605026. Review.

PMID:
19817595
3.

Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.

Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S1-8. doi: 10.1086/605061. Review.

PMID:
19817589
4.

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.

Postma MJ, Jit M, Rozenbaum MH, Standaert B, Tu HA, Hutubessy RC.

BMC Med. 2011 Jul 8;9:84. doi: 10.1186/1741-7015-9-84. Review.

5.

Rotavirus vaccines: development, current issues and future prospects.

Cunliffe NA, Bresee JS, Hart CA.

J Infect. 2002 Jul;45(1):1-9. Review.

PMID:
12217724
6.

Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?

Rheingans RD, Heylen J, Giaquinto C.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S48-55. Review.

PMID:
16397429
7.

[Rotavirus vaccination in Europe in 2010].

Grimprel E.

Bull Acad Natl Med. 2010 Nov;194(8):1451-62; discussion 1462-4. Review. French.

PMID:
22046709
8.

Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe? A rotavirus case study.

Brüggenjürgen B, Lorrot M, Sheppard FR, Rémy V.

Hum Vaccin Immunother. 2014;10(8):2290-4. doi: 10.4161/hv.29090. Review.

9.

A critical literature review of health economic evaluations of rotavirus vaccination.

Aballéa S, Millier A, Quilici S, Caroll S, Petrou S, Toumi M.

Hum Vaccin Immunother. 2013 Jun;9(6):1272-88. doi: 10.4161/hv.24253. Epub 2013 Apr 9. Review.

10.

Insights from global data for use of rotavirus vaccines in India.

Rao TS, Arora R, Khera A, Tate JE, Parashar U, Kang G; Indian Rotavirus Vaccine Working Group.

Vaccine. 2014 Aug 11;32 Suppl 1:A171-8. doi: 10.1016/j.vaccine.2014.03.029. Review.

11.

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe.

Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, Guarino A, Szajewska H, Usonis V.

J Pediatr Gastroenterol Nutr. 2008 May;46 Suppl 2:S38-48. doi: 10.1097/MPG.0b013e31816f7a10. Review. No abstract available.

PMID:
18460971
12.

Global mortality associated with rotavirus disease among children in 2004.

Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S9-S15. doi: 10.1086/605025. Review.

PMID:
19817620
13.

Rotavirus vaccination in developing countries.

Babji S, Kang G.

Curr Opin Virol. 2012 Aug;2(4):443-8. doi: 10.1016/j.coviro.2012.05.005. Epub 2012 Jun 13. Review.

PMID:
22698800
14.

Synthesizing evidences for policy translation: a public health discourse on rotavirus vaccine in India.

Panda S, Das A, Samanta S.

Vaccine. 2014 Aug 11;32 Suppl 1:A162-70. doi: 10.1016/j.vaccine.2014.03.037. Review.

15.

Development of candidate rotavirus vaccines derived from neonatal strains in India.

Glass RI, Bhan MK, Ray P, Bahl R, Parashar UD, Greenberg H, Rao CD, Bhandari N, Maldonado Y, Ward RL, Bernstein DI, Gentsch JR.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S30-5. Review.

PMID:
16088802
16.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

PMID:
19817612
17.

Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?

Mirzayeva R, Steele AD, Parashar UD, Zaman K, Neuzil KM, Nelson EA.

Vaccine. 2009 Nov 20;27 Suppl 5:F120-9. doi: 10.1016/j.vaccine.2009.09.039. Review.

PMID:
19931711
18.

[Contribution of mathematical modeling to vaccination decision making. Examples from varicella, rotavirus and papillomavirus vaccinations].

Lévy-Bruhl D.

Bull Acad Natl Med. 2010 Nov;194(8):1545-56; discussion 1557-8. Review. French.

PMID:
22046716
19.

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources.

Bilcke J, Beutels P.

Pharmacoeconomics. 2009;27(4):281-97. doi: 10.2165/00019053-200927040-00002. Review.

PMID:
19485425

Supplemental Content

Support Center